Skip to content

Is HIV causing cardiovascular disease by its own effects on cholesterol?

Triple nuke combination of AZT/3TC/tenofovir below current standards as a first-line regimen

Prezista (darunavir) approved for treatment-experienced patients in Europe

HIV treatment may need to start above 300 CD4s in HIV/hepatitis C coinfected, study suggests

HIV vaccine trials: measurements may overestimate participant understanding

Siblings of HIV/HCV coinfected patients also have higher mortality risk

HIV-positive women often infected with multiple HPV subtypes

Two circumcision studies halted after circumcised men's HIV risk halved

Malaria treatment compromised by suppressed immunity in HIV-positive adults